
Keywords: prostatic neoplasms; biological markers; sensitivity and specificity; prostate-specific antigen; risk; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; CCP; cell cycle progression; DRE; di